TPC's Bullish Ratings Are a Trap: The Smart Money Is Selling

Generated by AI AgentTheodore QuinnReviewed byAInvest News Editorial Team
Friday, Jan 16, 2026 10:48 am ET4min read
Aime RobotAime Summary

- Analysts rate

as a Hold with a $66.33 average target, suggesting limited downside.

- Insiders sold 10.68M shares vs. 1.83M bought, signaling a systematic exit.

- CEO Gary Smalley sold 12.9M shares indirectly, contrasting with his minimal direct purchases.

-

reduced its stake by 30%, reflecting broader institutional caution.

- Record $21.6B backlog clashes with insider selling and institutional exits, raising execution risks.

The setup here is textbook. On one side, you have the Wall Street chorus singing a bullish tune. The consensus rating from five analysts is a

, but the average price target sits at $66.33, implying a mere forecasted downside of -2.17% from recent levels. That's a whisper of skepticism, easily drowned out by the three Buy ratings. The narrative is clear: the stock is a hold, but the smart money is already pricing in a slight climb.

On the other side, the smart money is doing the opposite. In the last 100 insider trades, the signal is a stark, negative

. Insiders sold 10.68M shares while buying just 1.83M shares. This isn't a few scattered sales; it's a systematic exit. The alignment of interest is broken.

Zoom in on the CEO, Gary Smalley, and the disconnect becomes personal. He purchased only

in the past year. Meanwhile, his indirect selling-through gifts and sales of stock he controls-amounts to 12.9 million shares. That's a massive net outflow from the top. When the person who runs the company is selling tens of millions of dollars in stock while the analysts are telling you to hold, you have to ask: who is really in the know?

This is the classic pump-and-dump signal. The analyst hype creates a bullish narrative that can drive the stock higher, giving insiders a perfect window to cash out. The skin in the game is clearly not with the CEO. The smart money is selling, and the consensus rating is a distraction.

The Smart Money Exit: Institutional Accumulation Is a Myth

The insider selling isn't happening in a vacuum. The broader smart money is echoing that caution. The numbers show a market where institutional ownership is high but commitment is low. The company's float is dominated by funds, with

. That sounds like strong backing, but the average portfolio allocation tells a different story: a mere 0.21%. This is the hallmark of a passive index fund, not a concentrated bet on a stock's future. More telling is the direction of flow. Despite the high ownership percentage, there's been a net decrease in institutional holdings. The total institutional share count fell by 0.06MM shares in the latest quarter. The largest player, BlackRock, is the most visible example of this retreat. Its stake was slashed by nearly 30%, selling 1.63 million shares to reduce its position from 5.44M to 3.82M shares. This isn't a minor adjustment; it's a significant reduction from one of the world's biggest asset managers.

Put this together with the insider data, and the picture is clear. The smart money isn't accumulating; it's trimming. The widespread selling confirms the insider exit isn't an outlier. It's part of a coordinated, cautious sentiment. When the whales are bailing, the skin in the game is being removed from the deck.

The Backlog Trap: Record Orders, But Skin in the Game Is Missing

The company's operational strength is undeniable.

just reported a , a figure that has surged 54% year-over-year. That's the kind of visibility that builds confidence. The recent Q3 results backed it up, with revenue jumping 31% and the company delivering a solid adjusted EPS of $1.15. On the surface, it looks like a perfect story: record orders, strong execution, and rising profits.

But the smart money looks past the headline numbers to the quality of that growth. The recent earnings report shows the path to that adjusted EPS was paved with a massive operating cash flow of $289.1 million. That's a record, yes, but it's not necessarily a pure indicator of high-margin project success. In construction, large cash inflows can also stem from timing, billing cycles, or even one-time adjustments. The real test is how quickly that backlog converts into sustainable, profitable earnings without new cost overruns or disputes. The company's own note about the absence of certain net unfavorable adjustments last quarter is a reminder that past performance can be a bit of a mirage.

The market has already priced in a lot of this good news. The stock's

suggests the bullish narrative is well underway. That's the trap. When the smart money is selling while the stock is rallying on record backlog, it often means the easy money has been made. The skin in the game-the insider and institutional bets-is being removed just as the story gets hyped. The backlog is a promise, not a guarantee. The smart money is watching the execution risk, not the order book.

What to Watch: Specific Signals That Would Change the Thesis

The thesis here is clear: the smart money is exiting. To prove it wrong, you need to see a reversal in the concrete actions of those with the most skin in the game. Watch for these specific signals.

First, look for any significant insider buying, especially from the CEO or board. The current pattern is one of systematic selling, with the CEO's indirect sales dwarfing his direct purchases. A change in alignment would show up as a meaningful purchase from Gary Smalley or a director like Ronald Tutor, who has sold millions of shares. The recent

are a red flag; they are a tax-efficient way to transfer wealth, not a vote of confidence. If that changes, and insiders start buying at market prices, it would be a major signal. But for now, the only buying we see is from a director, Peter Arkley, who purchased 2.56 million shares in November. That's a large bet, but it's from one person, not a coordinated move from the top.

Second, monitor the next earnings report for a shift from cash flow-driven results to sustained, high-margin profitability. The recent quarter showed a massive

, but that doesn't always equal high-margin earnings. The real test is whether the company can convert its record backlog into consistent, profitable work without the swings that plagued past quarters. The guidance raise is a positive, but the market is already pricing in that optimism. The stock's suggests the easy money from the backlog news has been made. The next report needs to show the quality of that growth is improving, not just the volume.

The key risk is that the stock's current price already reflects the strong backlog, leaving little room for upside if execution falters. With shares trading near $72 and a narrative fair value only about 10% higher, the margin for error is thin. The smart money is selling, and the institutional retreat confirms the caution. If the next earnings report fails to show a clear path to sustained profitability, the thesis of an exit will be validated. The backlog is a promise; the smart money is waiting to see if it gets delivered.

Comments



Add a public comment...
No comments

No comments yet